Hepatitis C Conference for the Generalist and Specialist (Viral Hepatitis)

Hepatitis C Conference for the Generalist and Specialist
Left untreated, chronic hepatitis C could result in a 1.5 fold increase in cirrhosis in the next 15-20 years. The current combination regimen of interferon and ribavirin has

HCD Health.com : : : Online Physician Community
Chronic hepatitis C presents differently in end-stage renal disease patients Last Updated: 2005-09-21 14:11:21 -0400 (Reuters Health) NEW YORK (Reuters Health) - The presentation and natural history of

HEPATITIS C TREATMENT / INTERFERON
Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplantrecipients. Transplantation 1995;59:1426-31. Perrillo R, Tamburro C, Regenstein F, Balart L

Chronic Hepatitis C: Current Disease Management
Chronic hepatitis C varies greatly in its course and outcome. At one end of the spectrum are patients who have no signs or symptoms of liver disease and completely normal

CASL Hepatology Fellowship
The recommended treatment for chronic hepatitis C is with a combination of interferon alpha 2b and ribavirin. The dose of interferon is 3 mu TIW, and the dose of ribavirin is 1000 mg for patients